Marta R. S.
- Country
- Spain
- Department
- Servicio de Hematología
Research Overview
- Phase 3 Multicenter Randomized Open-Label Study of Venetoclax and Dexamethasone Versus Pomalidomide and Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
- Phase II Multicenter Study of Carfilzomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma Patients ≤70 Years
- Phase II Multicenter Study of Iberdomide and Dexamethasone, Alone or with Daratumumab, in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 9 of 49 partner sites.
Specializations
Multiple Myeloma Treatment
The investigator specializes in the treatment of multiple myeloma, with particular emphasis on developing innovative therapeutic approaches for various stages of the disease. Their research encompasses both newly diagnosed and relapsed/refractory cases.
- Treatment of t(11;14)-positive multiple myeloma
- Novel combination therapies
- Management of high-risk disease variants
Their work extends to evaluating targeted treatments utilizing venetoclax and immunomodulatory agents.
Early Intervention Strategies
The investigator focuses on developing treatment approaches for asymptomatic multiple myeloma patients, particularly those at high risk of disease progression. Their expertise includes evaluation of stem cell transplantation outcomes.
- High-risk smoldering myeloma management
- Autologous stem cell transplantation
- Minimal residual disease assessment
Their research incorporates advanced monitoring techniques including multiparametric flow cytometry.
Novel Therapeutic Combinations
The investigator explores innovative treatment combinations for transplant-ineligible patients with multiple myeloma. Their work includes evaluation of iberdomide-based regimens and combination approaches with established therapies.
- Iberdomide combination studies
- Treatment strategies for elderly patients
- Response assessment protocols
Their research adheres to International Myeloma Working Group criteria for response evaluation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.